This award was first presented at the ‘3rd International Conference on the Reduction of Drug Related Harm’ in Melbourne in 1992 and is given to an individual, group or organisation that has made an outstanding contribution to harm reduction at an international level.
The award aims to recognise work in any of the following areas:
There is no cash prize for this award; the winner is presented with a trophy and has their name listed on the HRI website.
Nomination criteria
Nominations are for individuals, groups or organisations working at the community level, national and/or international levels.
The following criteria, with a focus on ‘international significance,’ are considered and assessed in reviewing the nominees:
Background
The award is named after Sir Humphry Rolleston, President of the Royal College of Physicians who chaired the UK Departmental Committee on Morphine and Heroin Addiction. In 1926 the committee concluded that the prescription of heroin or morphine could be regarded as legitimate medical treatment for those who required it – a decision that epitomises a benign, pragmatic and humane approach to drug problems, and was a landmark event in the history of harm reduction.
Previous Winners
Brought to you by:
In partnership with: